The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback